1. Home
  2. COCP vs ANY Comparison

COCP vs ANY Comparison

Compare COCP & ANY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • ANY
  • Stock Information
  • Founded
  • COCP N/A
  • ANY N/A
  • Country
  • COCP United States
  • ANY United States
  • Employees
  • COCP N/A
  • ANY N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • ANY Finance: Consumer Services
  • Sector
  • COCP Health Care
  • ANY Finance
  • Exchange
  • COCP Nasdaq
  • ANY Nasdaq
  • Market Cap
  • COCP 15.3M
  • ANY 12.2M
  • IPO Year
  • COCP N/A
  • ANY N/A
  • Fundamental
  • Price
  • COCP $1.43
  • ANY $0.59
  • Analyst Decision
  • COCP Strong Buy
  • ANY Strong Buy
  • Analyst Count
  • COCP 1
  • ANY 1
  • Target Price
  • COCP $7.00
  • ANY $3.00
  • AVG Volume (30 Days)
  • COCP 17.3K
  • ANY 309.8K
  • Earning Date
  • COCP 05-12-2025
  • ANY 05-12-2025
  • Dividend Yield
  • COCP N/A
  • ANY N/A
  • EPS Growth
  • COCP N/A
  • ANY N/A
  • EPS
  • COCP N/A
  • ANY N/A
  • Revenue
  • COCP N/A
  • ANY $16,608,000.00
  • Revenue This Year
  • COCP N/A
  • ANY N/A
  • Revenue Next Year
  • COCP N/A
  • ANY N/A
  • P/E Ratio
  • COCP N/A
  • ANY N/A
  • Revenue Growth
  • COCP N/A
  • ANY N/A
  • 52 Week Low
  • COCP $1.12
  • ANY $0.36
  • 52 Week High
  • COCP $3.26
  • ANY $1.90
  • Technical
  • Relative Strength Index (RSI)
  • COCP 48.70
  • ANY 51.32
  • Support Level
  • COCP $1.23
  • ANY $0.43
  • Resistance Level
  • COCP $1.44
  • ANY $0.55
  • Average True Range (ATR)
  • COCP 0.13
  • ANY 0.04
  • MACD
  • COCP 0.03
  • ANY 0.01
  • Stochastic Oscillator
  • COCP 78.38
  • ANY 73.92

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

Share on Social Networks: